Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JN.1: The Present Public Health Concern Pertains to the Emergence of a Novel Variant of COVID-19
Sakif Ahamed Khan, Mohiuddin Ahmed Bhuiyan, Syed Masudur Rahman Dewan
Environmental Health Insights (2024) Vol. 18
Open Access | Times Cited: 16

Showing 16 citing articles:

H10N5 and H3N2 Outbreak 2024: The First-Ever Co-Infection With Influenza A Viruses Has Been Culpable for the Contemporary Public Health Crisis
Chowdhury Ibnun Nafiz, Anika Tasnim Marlia, Syed Masudur Rahman Dewan
Environmental Health Insights (2024) Vol. 18
Open Access | Times Cited: 6
The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
Yishan Lu, Danyi Ao, Xuemei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 6
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines
Yaniv Lustig, Noam Barda, Yael Weiss-Ottolenghi, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126010-126010
Closed Access | Times Cited: 5
JN.1 and the ongoing battle: unpacking the characteristics of a new dominant COVID-19 variant
Reza Eshraghi, Ashkan Bahrami, Motahare Karimi Houyeh, et al.
Pathogens and Global Health (2024) Vol. 118, Iss. 6, pp. 453-458
Closed Access | Times Cited: 5
Fortifying defenses: Tactical safety protocols for COVID-19 sub-variant JN.1 in healthcare and laboratory settings
Shazima Sheereen, Mohnish Zulfikar Manva, Shamama Sheereen
Journal of Family Medicine and Primary Care (2025) Vol. 14, Iss. 1, pp. 78-84
Open Access
The JN.1 variant of COVID-19: immune evasion, transmissibility, and implications for global health
A. Siddiqui, Imshaal Musharaf, Bashar Haruna Gulumbe
Therapeutic Advances in Infectious Disease (2025) Vol. 12
Open Access
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Vaccine (2025) Vol. 54, pp. 126960-126960
Closed Access
Present Public Health Concern: Could the Transmission of the JN.1 Variant of COVID-19 Place Bangladesh at Risk of Transmitting the Disease?
Anika Tasnim Marlia, Chowdhury Ibnun Nafiz, Irin Dewan, et al.
Environmental Health Insights (2024) Vol. 18
Open Access | Times Cited: 3
Avian Influenza A (H5N1) Outbreak 2024 in Cambodia: Worries Over the Possible Spread of the Virus to Other Asian Nations and the Strategic Outlook for its Control
Farhana Yesmin Nidra, Mayesha Bintey Monir, Syed Masudur Rahman Dewan
Environmental Health Insights (2024) Vol. 18
Open Access | Times Cited: 1
In silico investigation of potential COVID-19-associated microRNA signatures
Seyedehsadaf Asfa, Didem Ökmen, Athanasia Pavlopoulou
Çukurova medical journal (Online)/Çukurova medical journal (2024) Vol. 49, Iss. 1, pp. 170-180
Open Access
Public Health Emergence: Challenges and Prospects for the Future of Herd Immunity to Reduce the Negative Impact of Disease X in Low- and Middle-Income Countries
Proma Rani Das, Sakif Ahamed Khan, Mohammad Safiqul Islam, et al.
Clinical Pathology (2024) Vol. 17
Open Access
Performance of and Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostics Based on Symptom Onset and Close Contact Exposure: An Analysis From the Test Us at Home Prospective Cohort Study
Carly Herbert, Biqi Wang, Honghuang Lin, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access
Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi
Bulletin of the National Research Centre/Bulletin of the National Research Center (2024) Vol. 48, Iss. 1
Open Access
Coronil biochemically inhibits the interaction of various clinically relevant mutants of SARS-CoV-2 Spike Proteins (Omicron Variants) with human ACE2 receptor
Acharya Balkrishna, Rishabh Dev, Sandeep Kumar, et al.
Research Square (Research Square) (2024)
Open Access
Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 Spike Proteins with human ACE2 receptor
Acharya Balkrishna, Rishabh Dev, Sandeep Kumar, et al.
Phytomedicine Plus (2024) Vol. 5, Iss. 1, pp. 100705-100705
Open Access
JN. 1 and cardiac-related clinical manifestations: a current public health concern
Sangeeta Chhotaray, Priyank Sahoo, Suman Kumar Mekap, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
COVID-19 treatment: Nattokinase, a fibrinolytic serine protease is the low-hanging fruit
Basil N. Okeahialam
Santosh University Journal of Health Sciences (2024) Vol. 10, Iss. 2, pp. 279-282
Closed Access
Page 1

Scroll to top